JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB91279

Anti-liver Arginase antibody

4

(3 Reviews)

|

(118 Publications)

Rabbit Polyclonal Liver Arginase antibody. Suitable for IP, WB and reacts with Mouse, Rat samples. Cited in 118 publications.

View Alternative Names

Arginase-1, Liver-type arginase, Type I arginase, Arg1

2 Images
Immunoprecipitation - Anti-liver Arginase antibody (AB91279)
  • IP

Unknown

Immunoprecipitation - Anti-liver Arginase antibody (AB91279)

Liver Arginase was immunoprecipitated using 0.5mg mouse liver tissue lysate, 5μg of Rabbit polyclonal to Liver Arginase and 50μl of protein G magnetic beads (+). No antibody was added to the control (-).
The antibody was incubated under agitation with Protein G beads for 10min, mouse liver tissue lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.
Proteins were eluted by addition of 40μl SDS loading buffer and incubated for 10min at 70oC; 10μl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab91279.
Secondary : Mouse monoclonal [SB62a] Secondary Antibody to Rabbit IgG light chain (HRP) (ab99697).
Band : 37, 40kDa : liver Arginase

All lanes:

Immunoprecipitation - Anti-liver Arginase antibody (ab91279)

Predicted band size: 35 kDa

false

Western blot - Anti-liver Arginase antibody (AB91279)
  • WB

Unknown

Western blot - Anti-liver Arginase antibody (AB91279)

All lanes:

Western blot - Anti-liver Arginase antibody (ab91279) at 1 µg/mL

Lane 1:

Liver (Mouse) Tissue Lysate at 10 µg

Lane 2:

Liver (Rat) Tissue Lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-preadsorbed-ab97080'>ab97080</a>) at 1/5000 dilution

Predicted band size: 35 kDa

Observed band size: 37 kDa,40 kDa

true

Exposure time: 30s

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat

Applications

IP, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "5 µg/mL", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Key element of the urea cycle converting L-arginine to urea and L-ornithine, which is further metabolized into metabolites proline and polyamides that drive collagen synthesis and bioenergetic pathways critical for cell proliferation, respectively; the urea cycle takes place primarily in the liver and, to a lesser extent, in the kidneys.. Functions in L-arginine homeostasis in nonhepatic tissues characterized by the competition between nitric oxide synthase (NOS) and arginase for the available intracellular substrate arginine. Arginine metabolism is a critical regulator of innate and adaptive immune responses. Involved in an antimicrobial effector pathway in polymorphonuclear granulocytes (PMN). Upon PMN cell death is liberated from the phagolysosome and depletes arginine in the microenvironment leading to suppressed T cell and natural killer (NK) cell proliferation and cytokine secretion (By similarity). In group 2 innate lymphoid cells (ILC2s) promotes acute type 2 inflammation in the lung and is involved in optimal ILC2 proliferation but not survival (PubMed : 27043409). Plays a role in the immune response of alternatively activated or M2 macrophages in processes such as wound healing and tissue regeneration, immune defense against multicellular pathogens and parasites, and immune suppression and allergic inflammation; the regulatory outcome seems to be organ specific (PubMed : 19360123, PubMed : 20483789, PubMed : 23552798, PubMed : 23637937, PubMed : 7537672). In tumor-infiltrating dendritic cells (DCs) and myeloid-derived suppressor cells (MDSCs) plays a role in suppression of T cell-mediated antitumor immunity (PubMed : 19414774, PubMed : 23248265).
See full target information Arg1

Publications (118)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:8928 PubMed41062473

2025

Exercise facilitates post-stroke recovery through mitigation of neuronal hyperexcitability via interleukin-10 signaling.

Applications

Unspecified application

Species

Unspecified reactive species

A Schmidt-Pogoda,T Ruck,J K Strecker,M Hoppen,L Fazio,L Vinnenberg,B Maus,L Wachsmuth,M Cerina,K Diederich,S Lichtenberg,H Abberger,Lal Haertel,D Schafflick,G Meyer Zu Hörste,A M Herrmann,P Hundehege,V Narayanan,C Nelke,K Kruithoff,J Bosbach,E Vicari,T Ramcke,C Beuker,E Hadaschik,T Budde,C Faber,H Wiendl,W Hansen,S G Meuth,J Minnerup

Materials today. Bio 34:102217 PubMed40917510

2025

H-silicene nanosheets as a novel therapeutic approach for disuse muscle atrophy by modulating macrophage polarization.

Applications

Unspecified application

Species

Unspecified reactive species

Lubing Cai,Zhiqiang Zhang,Yangyang Chen,Yuqi Li,Ya-Xuan Zhu,Jiwu Chen,Yaying Sun

Bioactive materials 53:855-874 PubMed40822305

2025

Localised delivery of interleukin-13 from a PLGA microparticle embedded GelMA hydrogel improves functional and histopathological recovery in a mouse contusion spinal cord injury model.

Applications

Unspecified application

Species

Unspecified reactive species

Ciara M Walsh,Ruth Colbert,James P Reynolds,Emily Dunne,Emmanuelle D Aiyegbusi,Ross O'Carroll,Jacek K Wychowaniec,Takahiro Masuda,Klaus-Peter Knobeloch,Marco Prinz,Dermot F Brougham,Dearbhaile Dooley

Frontiers in aging neuroscience 17:1579411 PubMed40443793

2025

Mirodenafil improves cognitive function by reducing microglial activation and blood-brain barrier permeability in ApoE4 KI mice.

Applications

Unspecified application

Species

Unspecified reactive species

Yejin Park,Subin Moon,Harry Jung,Songyi Park,Ju Won Kim,Dan-Gyeong Song,Yong-Ho In,Sang Won Han,Jong-Hee Sohn,Chan Hee Lee

Nature communications 16:1674 PubMed39955276

2025

Janus decellularized membrane with anisotropic cell guidance and anti-adhesion silk-based coatings for spinal dural repair.

Applications

Unspecified application

Species

Unspecified reactive species

Xuewei Bi,Zhinan Mao,Linhao Li,Yilin Zhang,Lingbing Yang,Sen Hou,Juan Guan,Yufeng Zheng,Xiaoming Li,Yubo Fan

International journal of biological sciences 21:475-489 PubMed39781451

2025

USP25 stabilizes STAT6 to promote IL-4-induced macrophage M2 polarization and fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Yahan Xu,Jing Liu,Jingzeng Wang,Jiayao Wang,Peixiang Lan,Tao Wang

Disease models & mechanisms 18: PubMed39780710

2025

Development of a genetically tailored implantation hepatocellular carcinoma model in Oncopigs by somatic cell CRISPR editing.

Applications

Unspecified application

Species

Unspecified reactive species

Lobna Elkhadragy,Maximillian J Carlino,Luke R Jordan,Thomas Pennix,Nahed Ismail,Grace Guzman,Jonathan P Samuelson,Lawrence B Schook,Kyle M Schachtschneider,Ron C Gaba

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 72:569-584 PubMed39240248

2024

Frequent Icing Stimulates Skeletal Muscle Regeneration Following Injury With Necrosis in a Small Fraction of Myofibers in Rats.

Applications

Unspecified application

Species

Unspecified reactive species

Masato Kawashima,Itsuki Nagata,Erika Terada,Asano Tamari,Mami Kurauchi,Tohma Sakuraya,Takahiro Sonomura,Eri Oyanagi,Hiromi Yano,Jonathan M Peake,Takamitsu Arakawa

Cell reports. Medicine 5:101711 PubMed39232498

2024

Loss of p53 and SMAD4 induces adenosquamous subtype pancreatic cancer in the absence of an oncogenic KRAS mutation.

Applications

Unspecified application

Species

Unspecified reactive species

Daowei Yang,Xinlei Sun,Rohan Moniruzzaman,Hua Wang,Citu Citu,Zhongming Zhao,Ignacio I Wistuba,Huamin Wang,Anirban Maitra,Yang Chen

Journal of biomedical materials research. Part B, Applied biomaterials 112:e35469 PubMed39205328

2024

3D-printed silicate porous bioceramics promoted the polarization of M2-macrophages that enhanced the angiogenesis in bone regeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Chengwu Zang,Min Che,Hang Xian,Xin Xiao,Tengfei Li,Yongxiang Chen,Yaxiong Liu,Rui Cong
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com